Synakis

Synakis has developed a novel ocular hydrogel that is injectable, biocompatible, biodegradable, low swelling and transparent. Our biomaterial can be used as a vitreous substitute for vitreoretinal surgery and to deliver engineered therapeutics to treat leading causes of blindness.